DUDLEY ROBERT MICHAEL (Chief Executive Officer) purchased 29.2% of their position (18.61K shares) of TRANSCODE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $48.7K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/22/2023ACC: 0001104659-23-073872
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2021
+18.61K
Net shares
Net buyer
$48.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
18.61K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.61K
Price / share
$2.55
Trade value
$16.85K
% of position
10.4%
6/20/2023
63.66K→70.26K
Common Stock
Direct
Shares
+12K
Price / share
$2.65
Trade value
$31.82K
% of position
17.1%
6/21/2023
70.26K→82.26K
Total
Net shares
+18.61K
Net value
$48.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/20/2023 | P · Purchase | +6.61K | $2.55 | $16.85K | 10.4% | 63.66K | 70.26K |
| Common Stock Direct | 6/21/2023 | P · Purchase | +12K | $2.65 | $31.82K | 17.1% | 70.26K | 82.26K |
| Total | +18.61K | $48.66K | ||||||
Derivative Transactions0
No derivative transactions reported